A detailed history of Bellevue Group Ag transactions in Ideaya Biosciences, Inc. stock. As of the latest transaction made, Bellevue Group Ag holds 7,200 shares of IDYA stock, worth $184,392. This represents 0.0% of its overall portfolio holdings.

Number of Shares
7,200
Previous 5,700 26.32%
Holding current value
$184,392
Previous $200,000 14.0%
% of portfolio
0.0%
Previous 0.0%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$30.37 - $43.05 $45,555 - $64,574
1,500 Added 26.32%
7,200 $228,000
Q2 2024

Aug 14, 2024

BUY
$34.37 - $43.46 $82,488 - $104,304
2,400 Added 72.73%
5,700 $200,000
Q1 2024

May 15, 2024

BUY
$34.2 - $47.13 $112,860 - $155,529
3,300 New
3,300 $144,000
Q2 2022

Aug 11, 2022

SELL
$8.28 - $13.88 $382,535 - $641,256
-46,200 Closed
0 $0
Q1 2022

May 13, 2022

SELL
$11.18 - $24.02 $8,944 - $19,216
-800 Reduced 1.7%
46,200 $517,000
Q4 2021

Feb 10, 2022

BUY
$20.95 - $26.88 $984,650 - $1.26 Million
47,000 New
47,000 $1.11 Million

Others Institutions Holding IDYA

About IDEAYA Biosciences, Inc.


  • Ticker IDYA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 48,067,700
  • Market Cap $1.23B
  • Description
  • IDEAYA Biosciences, Inc., a synthetic lethality-focused precision medicine oncology company, focuses on the discovery and development of targeted therapeutics for patient populations selected using molecular diagnostics. The company's lead product candidates include IDE397, a methionine adenosyltransferase 2a inhibitor that is in Phase I clinica...
More about IDYA
Track This Portfolio

Track Bellevue Group Ag Portfolio

Follow Bellevue Group Ag and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bellevue Group Ag, based on Form 13F filings with the SEC.

News

Stay updated on Bellevue Group Ag with notifications on news.